Internal Medicine — Old Core Academic Day Lectures (Until Sep 2023)
Hemolytic anemia
EPAs mapped to this activity
None.
Competencies covered in this activity
| 1. Practise medicine within their defined scope of practice and expertise | ||||||
| 1.4. Apply knowledge of the following systems, clinical scenarios, conditions, diseases and therapies applicable to Internal Medicine, including the manifestations, investigation, and management | ||||||
| 1.4.8. Hematologic | ||||||
| 1.4.8.1. Findings and investigations | ||||||
| 1.4.8.1.1. Anemia | ||||||
| 1.4.8.1.2. Eosinophilia | ||||||
| 1.4.8.1.3. Lymphadenopathy | ||||||
| 1.4.8.1.4. Splenomegaly | ||||||
| 1.4.8.2. Disorders | ||||||
| 1.4.8.2.1. Congenital and acquired bleeding disorders including, but not limited to hemophilia, diffuse intravascular coagulation, and thrombocytopenic purpura | ||||||
| 1.4.8.2.2. Hemoglobinopathies | ||||||
| 1.4.8.2.3. Hypercoaguable states | ||||||
| 1.4.8.2.4. Leukemia | ||||||
| 1.4.8.2.5. Lymphoma | ||||||
| 1.4.8.2.6. Multiple myeloma and other dysproteinemias | ||||||
| 1.4.8.2.7. Myelodysplastic | ||||||
| 1.4.8.2.8. Myeloproliferative | ||||||
| 1.4.8.2.9. Porphyria | ||||||
| 1.4.8.2.10. Thrombophilia | ||||||
| 1.4.8.2.11. Venous thromboembolic disease | ||||||
| 1.4.8.3. Therapies | ||||||
| 1.4.8.3.1. Anticoagulant therapy | ||||||
| 1.4.8.3.2. Prophylaxis for venous thromboembolic disease | ||||||
| 1.4.8.3.3. Transfusion of blood products | ||||||
Training experiences included in this activity
None.